Uterine Fibroids News and Research

Latest Uterine Fibroids News and Research

Neurocrine reports net loss of $1.2 million for first quarter 2015

Neurocrine reports net loss of $1.2 million for first quarter 2015

OHTAC recommends MRgHIFU as possible cost-effective strategy for uterine fibroid treatment

OHTAC recommends MRgHIFU as possible cost-effective strategy for uterine fibroid treatment

Alternative treatment options for uterine fibroids

Alternative treatment options for uterine fibroids

Study compares cost, benefits, complications of uterine-sparing treatments for fibroids

Study compares cost, benefits, complications of uterine-sparing treatments for fibroids

VIVA physician selected as new Fellows in the Society of Interventional Radiology

VIVA physician selected as new Fellows in the Society of Interventional Radiology

Laparoscopic hysterectomy with morcellation safer than abdominal procedure for treating presumed fibroid uterus

Laparoscopic hysterectomy with morcellation safer than abdominal procedure for treating presumed fibroid uterus

BioSpecifics Technologies provides corporate update, reports Q4 and FY 2014 financial results

BioSpecifics Technologies provides corporate update, reports Q4 and FY 2014 financial results

Study: Risk of uterine sarcoma fairly low in women following hysterectomy

Study: Risk of uterine sarcoma fairly low in women following hysterectomy

Actavis provides overview of standalone global pharmaceutical development pipeline

Actavis provides overview of standalone global pharmaceutical development pipeline

Study finds unnecessary hysterectomy in 1 out of 5 cases

Study finds unnecessary hysterectomy in 1 out of 5 cases

Report supports potential of focused ultrasound to treat certain OCD patients

Report supports potential of focused ultrasound to treat certain OCD patients

FDA takes immediate steps to help reduce risk of spreading unsuspected uterine cancer

FDA takes immediate steps to help reduce risk of spreading unsuspected uterine cancer

InSightec's MRgFUS system approved in Japan for treatment of women with uterine fibroids

InSightec's MRgFUS system approved in Japan for treatment of women with uterine fibroids

Promising molecular diagnostic approach to endometriosis

Promising molecular diagnostic approach to endometriosis

Cholesterol-fighting statins inhibit uterine fibroid tumors that account for 50% of hysterectomies

Cholesterol-fighting statins inhibit uterine fibroid tumors that account for 50% of hysterectomies

New book offers advice on how to meet contraceptive needs of women with chronic medical problems

New book offers advice on how to meet contraceptive needs of women with chronic medical problems

InSightec to share new insights at FUS symposium

InSightec to share new insights at FUS symposium

BioSpecifics Technologies total revenue for second quarter decreases by 19%

BioSpecifics Technologies total revenue for second quarter decreases by 19%

BioSpecifics Technologies initiates CCH Phase 2 clinical trial in patients with lipoma

BioSpecifics Technologies initiates CCH Phase 2 clinical trial in patients with lipoma

Scientists make seminal breakthrough in understanding molecular basis of fibroadenoma

Scientists make seminal breakthrough in understanding molecular basis of fibroadenoma